Genprex, Inc. Other Current Liabilities
Genprex, Inc. (GNPX) had Other Current Liabilities of $2.03 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Other Liabilities, Current $2.03M.
- 2026-03-31: Other Liabilities, Current $1.70M.
- 2025-12-31: Other Liabilities, Current $1.43M; Other Liabilities, Current as first filed $1.43M.
- 2025-09-30: Other Liabilities, Current $932.26K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.03M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.70M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.43M 10-Q · filed 2026-08-14 | $1.43M 10-K · filed 2026-03-30 |
| 2025-09-30 | $932.26K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.51M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $616.15K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.43M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $938.17K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.08M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $1.66M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.86M 10-K · filed 2025-04-01 | |
| 2023-09-30 | $3.16M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.36M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $2.62M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $2.37M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $1.77M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.47M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $1.13M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $612.10K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $569.95K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $677.43K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $274.66K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $257.76K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $54.23K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $57.82K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $58.83K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $74.43K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $62.18K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $61.46K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $24.83K 10-Q/A · filed 2019-05-20 | |
| 2018-12-31 | $92.75K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $201.89K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $32.18K 10-Q · filed 2017-12-05 | |
| 2016-12-31 | $0.00 10-K · filed 2018-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |